I agree that this site is using cookies. You can find further informations here.
X
Fotheringham, Amelia K.
105  results:
?
1

Advanced Glycation End Products (AGEs) and Chronic Kidney D..:

Fotheringham, Amelia K. ; Gallo, Linda A. ; Borg, Danielle J..
Nutrients.  14 (2022)  13 - p. 2675 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Advanced Glycation End Products and Inflammation in Type 1 ..:

Du, Chenping ; Whiddett, Rani O. ; Buckle, Irina...
Cells.  11 (2022)  21 - p. 3503 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Kidney disease risk factors do not explain impacts of low d..:

Fotheringham, Amelia K. ; Solon-Biet, Samantha M. ; Bielefeldt-Ohmann, Helle...
iScience.  24 (2021)  11 - p. 103308 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Advanced glycation end products as predictors of renal func..:

Forbes, Josephine M. ; Le Bagge, Selena ; Righi, Samuel...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Adherence to Dietary and Physical Activity Guidelines in Au..:

Gallo, Linda A. ; Gallo, Tania F. ; Young, Sophia L....
Nutrients.  13 (2021)  10 - p. 3500 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Short Duration Alagebrium Chloride Therapy Prediabetes Does..:

Borg, Danielle J. ; Faridi, Pouya ; Giam, Kai Lin...
Metabolites.  11 (2021)  7 - p. 426 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Targeting the receptor for advanced glycation end products ..:

Le Bagge, Selena ; Fotheringham, Amelia K. ; Leung, Sherman S..
Medicinal Research Reviews.  40 (2020)  4 - p. 1200-1219 , 2020
Link: https://doi.org/10.1002/..
 
?
8

Circulating Levels of the Soluble Receptor for AGE (sRAGE) ..:

Fotheringham, Amelia K. ; Bagger, Jonatan I. ; Borg, Danielle J....
Nutrients.  12 (2020)  10 - p. 2928 , 2020
Link: https://doi.org/10.3390/..
 
?
9

Targeted mitochondrial therapy using MitoQ shows equivalent..:

Ward, Micheal S. ; Flemming, Nicole B. ; Gallo, Linda A....
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
10

Perinatal exposure to high dietary advanced glycation end p..:

Borg, Danielle J. ; Yap, Felicia Y. T. ; Keshvari, Sahar...
Islets.  10 (2017)  1 - p. 10-24 , 2017
Link: https://doi.org/10.1080/..
 
?
11

Vascular complications in diabetes: old messages, new thoug..:

Forbes, Josephine M. ; Fotheringham, Amelia K.
Diabetologia.  60 (2017)  11 - p. 2129-2138 , 2017
Link: https://doi.org/10.1007/..
 
?
12

The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers..:

Gallo, Linda A ; Ward, Micheal S ; Fotheringham, Amelia K...
The FASEB Journal.  30 (2016)  S1 - p. , 2016
Link: https://doi.org/10.1096/..
 
?
13

Once daily administration of the SGLT2 inhibitor, empaglifl..:

Gallo, Linda A. ; Ward, Micheal S. ; Fotheringham, Amelia K....
Scientific Reports.  6 (2016)  1 - p. , 2016
Link: https://doi.org/10.1038/..
 
?
14

Erratum: Once daily administration of the SGLT2 inhibitor, ..:

Gallo, Linda A. ; Ward, Micheal S. ; Fotheringham, Amelia K....
Scientific Reports.  6 (2016)  1 - p. , 2016
Link: https://doi.org/10.1038/..
 
?
15

Deletion of bone-marrow-derived receptor for AGEs (RAGE) im..:

Tesch, Greg ; Sourris, Karly C. ; Summers, Shaun A....
Diabetologia.  57 (2014)  9 - p. 1977-1985 , 2014
Link: https://doi.org/10.1007/..
 
1-15